title: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation.
abstract: BACKGROUND
  A diagnostic whole-body scan (WBS) is recommended 6 to 12 months after total thyroidectomy and radioactive iodide ablation in intermediate- or high-risk patients with differentiated thyroid cancer (DTC). The aim of this study was to evaluate the necessity of a diagnostic WBS after radioactive iodide ablation in intermediate-risk patients with DTC.
  
  
  METHODS
  A total of 438 subjects were included in the study: 183 low-risk subjects and 255 intermediate-risk subjects according to the American Thyroid Association guideline. All subjects diagnosed with DTC received 1,100 MBq (30 mCi) activity of radioiodine (I-131) following total thyroidectomy. On follow-up, all subjects underwent a diagnostic I-131 WBS after thyroid hormone withdrawal.
  
  
  RESULTS
  After initial radioactive iodide ablation, 95.1% of low-risk patients and 91.4% of intermediate-risk patients showed no uptake on diagnostic WBS (P=0.135). Intermediate-risk patients with stimulated thyroglobulin (Tg) levels higher than 2.0 ng/mL showed a greater rate of radioactive iodine uptake on diagnostic WBS. Four intermediate-risk patients showed recurrence during the 16 to 80 months follow-up period. Three of the four patients with recurrence showed no uptake on diagnostic WBS and had a stimulated Tg level less than 2.0 ng/mL.
  
  
  CONCLUSIONS
  A diagnostic I-131 WBS after radioactive iodide ablation in intermediate-risk patients with DTC may not be necessary. A large prospective study is necessary to determine the necessity of diagnostic WBS in intermediate-risk patients with DTC.
authors.affiliation: Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea.
authors.forename: Eon Ju
authors.initials: EJ
authors.lastname: Jeon
authors.affiliation: Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea.
authors.forename: Eui Dal
authors.initials: ED
authors.lastname: Jung
keywords: Ablation; Iodides; Radioactivity; Thyroid neoplasms
references.citation: Thyroid. 2007 Sep;17(9):883-8
references.pmid: 17956162
references.citation: J Clin Endocrinol Metab. 2003 Aug;88(8):3668-73
references.pmid: 12915653
references.citation: J Clin Endocrinol Metab. 2005 Mar;90(3):1440-5
references.pmid: 15613412
references.citation: Cancer. 1997 Jun 15;79(12):2414-23
references.pmid: 9191532
references.citation: J Nucl Med. 2004 Jun;45(6):988-94
references.pmid: 15181134
references.citation: Clin Endocrinol (Oxf). 2013 Apr;78(4):614-20
references.pmid: 22957654
references.citation: J Clin Endocrinol Metab. 1992 Sep;75(3):714-20
references.pmid: 1517360
references.citation: Surgery. 2000 Dec;128(6):1067-74
references.pmid: 11114644
references.citation: JAMA. 2006 May 10;295(18):2164-7
references.pmid: 16684987
references.citation: Clin Endocrinol (Oxf). 2004 Jul;61(1):61-74
references.pmid: 15212646
references.citation: Clin Oncol (R Coll Radiol). 2000;12(6):365-72
references.pmid: 11202090
references.citation: Eur J Endocrinol. 2004 Feb;150(2):105-12
references.pmid: 14763906
references.citation: J Clin Endocrinol Metab. 1997 Nov;82(11):3553-62
references.pmid: 9360506
references.citation: Endocr Pract. 2001 May-Jun;7(3):202-20
references.pmid: 11430305
references.citation: Laryngoscope. 2003 Dec;113(12):2102-7
references.pmid: 14660910
references.citation: Cancer. 2002 May 1;94(9):2511-6
references.pmid: 12015777
references.citation: Am J Med. 1994 Nov;97(5):418-28
references.pmid: 7977430
references.citation: Eur J Endocrinol. 2003 Jan;148(1):19-24
references.pmid: 12534353
references.citation: Thyroid. 2006 Feb;16(2):109-42
references.pmid: 16420177
references.citation: Thyroid. 2009 Nov;19(11):1167-214
references.pmid: 19860577
references.citation: J Clin Endocrinol Metab. 2006 Aug;91(8):2892-9
references.pmid: 16684830
references.citation: J Clin Endocrinol Metab. 2000 Jan;85(1):175-8
references.pmid: 10634383
references.citation: J Clin Endocrinol Metab. 2004 Jul;89(7):3402-7
references.pmid: 15240622
references.citation: Br J Radiol. 1977 Nov;50(599):799-807
references.pmid: 588901
references.citation: Cancer. 2003 Jan 1;97(1):90-6
references.pmid: 12491509
references.citation: Lancet. 2003 Feb 8;361(9356):501-11
references.pmid: 12583960
references.citation: Eur J Nucl Med. 1999 Nov;26(11):1448-52
references.pmid: 10552086
references.citation: J Clin Endocrinol Metab. 2004 Aug;89(8):3668-76
references.pmid: 15292285
references.citation: Cancer. 1998 Sep 1;83(5):1012-21
references.pmid: 9731906
references.citation: J Clin Endocrinol Metab. 2002 Apr;87(4):1499-501
references.pmid: 11932271
references.citation: N Engl J Med. 1998 Jan 29;338(5):297-306
references.pmid: 9445411
references.citation: Thyroid. 2005 Mar;15(3):267-73
references.pmid: 15785246
references.citation: Ann Intern Med. 1998 Oct 15;129(8):622-7
references.pmid: 9786809